BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Shanghai Ark Biopharmaceutical Advances First In Human Trial Of Long Acting Influenza Therapy AK0406

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a nove...

April 13, 2026 | News

NovogeneAIT Genomics Appointed To Advance PRECISE SG100K Proteomics Study In Singapore

NovogeneAIT Genomics announces its appointment as the designated service provider for the PRECISE-SG100K proteomics project. In this role, NovogeneAIT...

April 13, 2026 | News

Vivatides Secures USD 54 Million Series A To Advance Next Generation RNA Therapeutics Beyond Liver Targets

Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...

April 13, 2026 | News

Miracell Secures U.S. FDA Clearance For SMART M Cell System Advancing Regenerative Therapies

Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability Miracell, a...

April 13, 2026 | News

Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with Precision Health Research, S...

April 10, 2026 | News

Biocon Limited Launches Bosaya And Aukelso In The United States To Expand Bone Health Access

Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with ...

April 10, 2026 | News

Ascletis Pharma Inc. Advances Oral GLP 1 And Amylin Combination For Obesity Treatment

-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in...

April 09, 2026 | News

TriNetX Acquires Zetta Genomics Assets To Strengthen Multiomic Data Capabilities

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient c...

April 09, 2026 | News

Singlomics Biopharmaceuticals Doses First Patient In Phase I Trial Of DXP 106 Antibody

Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for...

April 09, 2026 | News

Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal

Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate considera...

April 09, 2026 | News

ATLATL And Daiichi Sankyo Partner To Advance APAC Driven Biopharma Innovation

ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreem...

April 09, 2026 | News

Amgen Reports Strong Phase 3 Results For Subcutaneous TEPEZZA In Thyroid Eye Disease

Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful R...

April 08, 2026 | News

Perceptive Discovery Expands In Vitro Capabilities To Accelerate Oncology Drug Development

Perceptive Discovery, a leading scientific partner to the global biopharmaceutical industry, announced a major expansion of its in vitro laboratory capabil...

April 07, 2026 | News

Neurocrine Biosciences To Acquire Soleno Therapeutics For $2.9 Billion To Strengthen Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and...

April 07, 2026 | News

Stay Connected